Joshua Ruch - 05 Feb 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Feb 2025, 16:01:42 UTC
Prior SEC filing
22 Jan 2025
Next SEC filing
23 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bridget Brown, Attorney-in-Fact

Key filing fact

Joshua Ruch filed Form 4 for GeneDx Holdings Corp. (WGS) on 07 Feb 2025.

Key facts

  • This page summarizes Joshua Ruch's Form 4 filing for GeneDx Holdings Corp. (WGS).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 07 Feb 2025, 16:01.

Change

  • Previous filing in this sequence was filed on 22 Jan 2025.
  • Current net transaction value: +$45,888.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WGS transaction

Class A Common Stock

Options Exercise

Transaction value
$45,888
Shares
+5,816
Change %
+53%
Price
$7.89
Shares after
16,799
Date
05 Feb 2025
Ownership
Direct
Footnotes
F1
WGS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
14,845
Date
05 Feb 2025
Ownership
See Kariba LLC
Footnotes
F2
WGS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,138
Date
05 Feb 2025
Ownership
See Rugu2 LLC
Footnotes
F2
WGS holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
149,284
Date
05 Feb 2025
Ownership
See VAAL Investment Partners Q9 LP
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-5,816
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Feb 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
5,816
Exercise price
$7.89
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects an acquisition of Class A Common Stock from the exercise of stock option at an exercise price of $7.89 per share as described in Table II. The increase in beneficial ownership of Class A Common Stock resulting therefrom is indicated in Table I.

Footnote F2

Mr. Ruch is (i) a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP ("Q9"), (ii) a managing member of RUGU2 LLC ("RUGU2") and (iii) a managing member of Kariba LLC ("Kariba"). As such, Mr. Ruch exercises voting and investment power with respect to the shares owned by Q9, RUGU2 and Kariba. Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Footnote F3

The option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .